Association of PD-L1 and IDO1 expression with JAK-STAT pathway activation in soft-tissue leiomyosarcoma.
Takeshi IwasakiKenichi KohashiYu TodaShin IshiharaYuichi YamadaYoshinao OdaPublished in: Journal of cancer research and clinical oncology (2020)
The results suggest the possible feasibility of the combined inhibition of PD-1/PD-L1 or IDO1 with IFN-γ-JAK-STAT pathway inhibition to treat soft tissue LMS.